TherapeuticsMD, Inc. Stock price

Equities

TXMD

US88338N2062

Pharmaceuticals

Delayed Nasdaq 10:16:19 2024-03-28 am EDT 5-day change 1st Jan Change
2.296 USD +2.03% Intraday chart for TherapeuticsMD, Inc. -0.19% +2.03%
Sales 2021 86.95M Sales 2022 69.96M Capitalization 52.92M
Net income 2021 -172M Net income 2022 112M EV / Sales 2021 3.26 x
Net Debt 2021 133M Net cash position 2022 29.31M EV / Sales 2022 0.34 x
P/E ratio 2021
-0.82 x
P/E ratio 2022
0.47 x
Employees 1
Yield 2021 *
-
Yield 2022
-
Free-Float 95.88%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.89%
1 week-0.19%
Current month-4.35%
1 month-3.14%
3 months-2.72%
6 months-21.91%
Current year+2.03%
More quotes
1 week
2.21
Extreme 2.2101
2.39
1 month
2.14
Extreme 2.1427
2.75
Current year
2.12
Extreme 2.12
2.75
1 year
1.95
Extreme 1.95
4.73
3 years
1.95
Extreme 1.95
73.50
5 years
1.95
Extreme 1.95
252.00
10 years
1.95
Extreme 1.95
563.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 13-05-31
Director of Finance/CFO - 23-08-16
Corporate Officer/Principal 46 18-11-30
Members of the board TitleAgeSince
Chairman 81 12-04-15
Director/Board Member 45 12-02-27
Director/Board Member 69 20-03-19
More insiders
Date Price Change Volume
24-03-28 2.296 +2.03% 2 830
24-03-27 2.25 0.00% 12,752
24-03-26 2.25 -1.75% 12,228
24-03-25 2.29 0.00% 14,714
24-03-22 2.29 -0.43% 36,752

Delayed Quote Nasdaq, March 28, 2024 at 10:16 am EDT

More quotes
TherapeuticsMD, Inc. is a healthcare company. The Company is focused on developing and commercializing products exclusively for women. It is engaged in conducting business by out-licensing its products and collecting royalties, after granting a license to commercialize the Company's IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands in the United States and its possessions and territories and assigning the Company's exclusive license to commercialize ANNOVERA in the United States and its possessions and territories to Mayne Pharma. ANNOVERA is a one-year (13 cycles) ring-shaped contraceptive vaginal system (CVS)). ANNOVERA, which is made with a silicone elastomer, contains segesterone acetate, a 19-nor progesterone derivative also known as Nestorone (SA) and ethinyl estradiol (EE). Its menopause portfolio includes IMVEXXY and BIJUV. IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
  1. Stock
  2. Equities
  3. Stock TherapeuticsMD, Inc. - Nasdaq